Procarta Biosystems Company
![](/storage/logos_100px/Procarta Biosystems.png)
Anti-microbial resistance. Procarta Biosystems Ltd aims to revolutionise the treatment of serious and life-threatening infection through the development of innovative new oligonucleotide-based antimicrobials. Goal is to radically improve patient well-being and aid in the global fight against AMR.
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Founded Date:
2007
Employees Number:
11-50
Estimated Revenue:
$1M to $10M
Register and Claim Ownership